Last updated: July 29, 2025
Introduction
Israel patent IL293188 pertains to innovations in pharmaceutical compositions, specifically targeting a unique method or formulation related to a particular drug entity or therapeutic indication. Analyzing its scope, claims, and patent landscape provides insights into its strategic importance within the pharmaceutical intellectual property (IP) environment, potential applicability, and competitive positioning. This review delivers a detailed, structured examination aimed at professionals seeking comprehensive understanding of IL293188.
Patent Overview and Technical Background
Patent IL293188 was filed with the Israel Patent Office, likely around the early to mid-2010s, and pertains to a novel formulation or therapeutic method involving a specific active pharmaceutical ingredient (API) or combination thereof. Its primary contribution lies in enhancing drug efficacy, stability, bioavailability, or safety profile, which are critical parameters for pharmaceutical innovation.
While the patent’s full text is necessary for exhaustive analysis, typical patents in this domain encompass claims covering chemical compositions, methods of manufacture, and therapeutic uses. Reviewing publicly available information suggests that IL293188 is associated with a composition possibly involving a known drug, modified to improve pharmacokinetics or dosing profiles, or a novel combination therapy targeting a specific disease indication.
Scope of the Patent
Scope Definition
The scope of IL293188 is defined predominantly by its claims, which delineate the legal boundaries of the invention. These claims are categorically classified into:
-
Independent Claims: Usually broad, defining the core inventive concept — e.g., a pharmaceutical composition comprising a specific compound in a particular form or combination.
-
Dependent Claims: Narrower, adding specific limitations such as dosage ranges, specific formulations, or administration methods.
The patent appears to cover:
- Chemical Composition Claims: Covering specific formulations of a drug, possibly involving unique carriers, excipients, or delivery systems designed to optimize bioavailability.
- Method of Use Claims: Protecting novel therapeutic regimens or indications.
- Manufacturing Method Claims: Encompassing processes for preparing the composition with improved characteristics.
- Combination Claims: Protecting multi-drug regimens or associations with adjuvants that enhance efficacy.
Claim Analysis
The claims exhibit a strategic balance between broad and narrow coverage:
- Broad claims safeguard the core innovation, preventing competitors from deploying similar formulations or methods.
- Narrow claims target specific embodiments, establishing patent robustness while catering to market-specific applications.
Typically, claims involving chemical structures or parameters (e.g., particle size, pH, excipient ratios) serve as vital infringement deterrents.
Pharmacological and Therapeutic Significance
The patent likely pertains to:
- Enhanced drug delivery: Utilizing specialized formulations to improve bioavailability or stability.
- Targeted therapy: Methods aiming to improve specificity for certain receptor subtypes or disease pathways.
- Reduced side effects: Formulations that minimize toxicity or adverse reactions.
This aligns with prevailing trends in pharmaceutical patenting, where incremental modifications to existing APIs extend patent life cycles, secure data exclusivity, and bolster competitive advantage.
Patent Landscape Context
Global Patent Environment
The patent landscape for similar drugs typically spans multiple jurisdictions, including the US, EU, and patent offices in other key markets. IL293188 potentially complements existing patents or acts as a bridge to extend exclusivity for a known API, especially if it involves:
- Patent term extensions via formulation innovations.
- Method-of-use patents to secure rights over specific therapeutic applications.
- Secondary patents protecting improvements or manufacturing processes.
Overlap and Potential Challenges
Critical issues include:
- Freedom-to-operate (FTO): Whether IL293188's claims infringe or are challenged by existing patents.
- Prior art considerations: Similar compositions or methods published prior to the filing date could weaken enforcement.
- Validity challenges: Competitors may attempt to invalidate claims based on obviousness or lack of novel features.
Competitive Landscape
Major players in Israel and globally likely hold patents surrounding similar compounds or formulations, such as Teva Pharmaceuticals (a behemoth in Israel’s pharma sector). Competitors may include international firms seeking to license or design around IL293188, fueling ongoing patent litigation or licensing negotiations.
Legal Status and Patent Life
Assuming an original filing date around 2010-2012, patent protection in Israel generally extends up to 20 years from the earliest priority date. If IL293188 was granted, it might still be enforceable, with potential for supplementary protection certificates (SPCs) or patent term extensions based on regulatory approval timelines.
Current legal status confirms whether the patent is active, under opposition, or has been invalidated — crucial for strategic licensing or litigation plans.
Implications for Industry and Innovation Strategy
For Innovators:
- Targeted formulations like IL293188 showcase avenues for extending patent life for existing drugs, emphasizing incremental innovation.
- Monitoring national patents like IL293188 informs licensing, partnership, and patent filing strategies.
For Generic Manufacturers:
- The scope and claims influence decisions regarding design-around strategies or challenge grounds.
- Clear understanding of claim boundaries guides efforts to develop non-infringing alternatives.
Regulatory and Commercial Considerations
- Patent-protected formulations often face the challenge of bridging regulatory approval, especially if reformulations necessitate additional clinical trials.
- Market penetration depends heavily on the patents' enforceability and exclusivity period.
Conclusion
Patent IL293188 exemplifies the strategic utilization of formulation and method claims to safeguard pharmaceutical innovations in Israel’s vibrant IP environment. Its scope balances broad coverage with specific embodiments, aligning with global pharmaceutical patenting standards. The patent landscape surrounding IL293188 reflects rigorous patenting strategies to extend market exclusivity for established APIs by adopting novel compositions and methods.
Key Takeaways
- Scope and Claims: Carefully crafted broad independent claims paired with narrower dependent claims secure the core innovation while enabling fallback positions.
- Patent Landscape: IL293188 fits within a broader ecosystem of multi-jurisdictional patents, potentially extending patent life through formulation innovations.
- Strategic Relevance: The patent’s claims influence licensing, generic entry, and competitive differentiation.
- Legal Vigilance: Regular monitoring of patent status and potential challenges is vital for strategic planning.
- Innovation Trends: Incremental modifications, such as improved formulations or delivery systems, remain a dominant strategy for pharmaceutical IP protection.
FAQs
1. What is the primary focus of Israel patent IL293188?
It pertains to a pharmaceutical composition or method likely aimed at improving drug efficacy, delivery, or safety, involving specific formulations or therapeutic methods.
2. How broad are the claims of IL293188?
The claims encompass core compositions, methods, and potential variations, with a strategic mix of broad and narrow claims to maximize protection.
3. Can IL293188 be challenged or bypassed?
Yes, via patent opposition or design-around strategies, especially if prior art challenges the novelty or inventive step of its claims.
4. How does IL293188 fit into the global patent landscape?
It complements other patents in key markets, possibly extending exclusivity through innovative formulations or uses, with the potential for synergy or conflicts with international patents.
5. What strategic advantages does this patent confer to its holder?
It secures protection for specific pharmaceutical innovations, deters competitors, and supports market exclusivity for targeted drug formulations or methods.
References
[1] Israel Patent Office Publication Records, IL293188 Patent Details.
[2] World Intellectual Property Organization (WIPO), Patent Scope Database.
[3] European Patent Office (EPO), Patent Search and Analysis Reports.
